Comparing PA-111 and PA-111A in healthy volunteers
Part of Hormones & metabolism clinical trials.
This trial tests how two study drugs, PA-111 and PA-111A, are processed by the body and how safe they are. Healthy volunteers are needed to compare the two drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female.
- Your body mass index (BMI) is between 18.0 and 30.0.
- You are 19 years old or older.
- You have not been in another clinical trial with an investigational drug in the last 6 months.
- You are generally healthy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how taking the study drug PA-111 with food changes how it is absorbed and how safe it is in healthy people. It helps researchers understand the best way to take the medication.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This trial tests a new version of a medicine (AD-228B) against the original (AD-2284) to see how they work in the body and if they are safe. Healthy volunteers are needed.
This trial tests if two different versions of the study drug AD-116A work the same way in the body. It only includes healthy adult men, so it's not a treatment for a specific disease but helps confirm the drug's safety and absorption.
This study tests how two experimental medications (AD-236A and AD-236B) interact with each other in the body and checks that they are safe for healthy adults. It helps determine how these drugs should be dosed for future treatments.
Hear when a new Mixed Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.